CSIMarket Company Name, Ticker, Industry, else..
 

Otonomy Inc   (NASDAQ: OTIC)

Otonomy Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

OTIC Sales vs. its Competitors Q3 2020


Comparing the current results to its competitors, Otonomy Inc reported Revenue decrease in the 3 quarter 2020 year on year by -60 %, slower than the combined decrease of the OTIC's competitors by -81.86 %, recorded in the same quarter.

• List of OTIC Competitors





Revenue Growth Comparisons




Net Income Comparison

Otonomy Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  OTIC Stock Performance Comparisons





  

Overall company Market Share Q3 2020
despite revenue deterioration, Otonomy Inc increased its market share in this segment.

company increased its market share in this segment to approximately 2.38 %.


<<  More on OTIC Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Otonomy Inc




Decibel Therapeutics Inc
Share Performance



+21.53%
This Quarter
Decibel Therapeutics Inc
Profile

Decibel Therapeutics Inc is a biotechnology company that focuses on developing treatments for hearing loss and related disorders.

More about Decibel Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 122.838 mill. $ - mill. $ -63.392 mill.


Eton Pharmaceuticals Inc
Share Performance



+68.65%
This Quarter
Eton Pharmaceuticals Inc
Profile

Eton Pharmaceuticals Inc operates as a specialty pharmaceutical company, focusing on the development and commercialization of innovative drug products. Their business model involves identifying market opportunities, acquiring or licensing drug candidates, and then developing and marketing these products to cater to specific patient needs.

More about Eton Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,851.810 mill. $ 105.279 mill. $ 12.688 mill.


Zevra Therapeutics Inc
Share Performance



-5.91%
Over The Past 5 Days
Zevra Therapeutics Inc
Profile

Zevra Therapeutics Inc operates on a business model that focuses on the development and commercialization of innovative therapeutics.

More about Zevra Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 683.290 mill. $ 128.855 mill. $ 57.904 mill.

Sources: Otonomy Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Otonomy Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.